Literature DB >> 23868920

Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds.

Pingping Hou1, Yanqin Li, Xu Zhang, Chun Liu, Jingyang Guan, Honggang Li, Ting Zhao, Junqing Ye, Weifeng Yang, Kang Liu, Jian Ge, Jun Xu, Qiang Zhang, Yang Zhao, Hongkui Deng.   

Abstract

Pluripotent stem cells can be induced from somatic cells, providing an unlimited cell resource, with potential for studying disease and use in regenerative medicine. However, genetic manipulation and technically challenging strategies such as nuclear transfer used in reprogramming limit their clinical applications. Here, we show that pluripotent stem cells can be generated from mouse somatic cells at a frequency up to 0.2% using a combination of seven small-molecule compounds. The chemically induced pluripotent stem cells resemble embryonic stem cells in terms of their gene expression profiles, epigenetic status, and potential for differentiation and germline transmission. By using small molecules, exogenous "master genes" are dispensable for cell fate reprogramming. This chemical reprogramming strategy has potential use in generating functional desirable cell types for clinical applications.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23868920     DOI: 10.1126/science.1239278

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  492 in total

Review 1.  Generation of pluripotent stem cells without the use of genetic material.

Authors:  Akon Higuchi; Qing-Dong Ling; S Suresh Kumar; Murugan A Munusamy; Abdullah A Alarfaj; Yung Chang; Shih-Hsuan Kao; Ke-Chen Lin; Han-Chow Wang; Akihiro Umezawa
Journal:  Lab Invest       Date:  2014-11-03       Impact factor: 5.662

Review 2.  Induced pluripotent stem cells in dermatology: potentials, advances, and limitations.

Authors:  Ganna Bilousova; Dennis R Roop
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

Review 3.  Hallmarks of pluripotency.

Authors:  Alejandro De Los Angeles; Francesco Ferrari; Ruibin Xi; Yuko Fujiwara; Nissim Benvenisty; Hongkui Deng; Konrad Hochedlinger; Rudolf Jaenisch; Soohyun Lee; Harry G Leitch; M William Lensch; Ernesto Lujan; Duanqing Pei; Janet Rossant; Marius Wernig; Peter J Park; George Q Daley
Journal:  Nature       Date:  2015-09-24       Impact factor: 49.962

4.  Stem cell gene SALL4 in aggressive hepatocellular carcinoma: a cancer stem cell-specific target?

Authors:  Elizabeth Yakaboski; Alexander Jares; Yupo Ma
Journal:  Hepatology       Date:  2014-05-27       Impact factor: 17.425

Review 5.  Mechanisms underlying the formation of induced pluripotent stem cells.

Authors:  Federico González; Danwei Huangfu
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-09-18       Impact factor: 5.814

Review 6.  Targeting the pancreatic β-cell to treat diabetes.

Authors:  Amedeo Vetere; Amit Choudhary; Sean M Burns; Bridget K Wagner
Journal:  Nat Rev Drug Discov       Date:  2014-02-14       Impact factor: 84.694

Review 7.  Chemical genomics for studying parasite gene function and interaction.

Authors:  Jian Li; Jing Yuan; Ken Chih-Chien Cheng; James Inglese; Xin-zhuan Su
Journal:  Trends Parasitol       Date:  2013-11-09

8.  Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of "factor-free" induced pluripotent stem cells.

Authors:  Johannes Kuehle; Soeren Turan; Tobias Cantz; Dirk Hoffmann; Julia D Suerth; Tobias Maetzig; Daniela Zychlinski; Christoph Klein; Doris Steinemann; Christopher Baum; Juergen Bode; Axel Schambach
Journal:  Mol Ther       Date:  2014-01-17       Impact factor: 11.454

Review 9.  Improving cardiac reprogramming for heart regeneration.

Authors:  Liu Liu; Ienglam Lei; Zhong Wang
Journal:  Curr Opin Organ Transplant       Date:  2016-12       Impact factor: 2.640

Review 10.  Strategies for Oral Mucosal Repair by Engineering 3D Tissues with Pluripotent Stem Cells.

Authors:  Kyle J Hewitt; Yulia Shamis; Behzad Gerami-Naini; Jonathan A Garlick
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-12-01       Impact factor: 4.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.